Keyphrases
Protease Inhibitors
100%
Bortezomib
100%
Activity-based Probes
100%
Living Cells
40%
Active Sites
20%
Dipeptide
20%
Mode of Action
20%
Hematological Malignancies
20%
Pharmacologic
20%
Multiple Myeloma
20%
MG132
20%
Activity Patterns
20%
Myeloma Cells
20%
Cultured Cells
20%
Velcade
20%
Site-directed
20%
U.S. Food
20%
Proteasome Activity
20%
Proteasomal Activity
20%
Permeant
20%
Relapsed or Refractory multiple Myeloma
20%
Boronic Acid
20%
Crude Cell Extract
20%
Pharmacology, Toxicology and Pharmaceutical Science
Bortezomib
100%
Proteasome Inhibitor
100%
Multiple Myeloma
28%
Benzyloxycarbonylleucylleucylleucinal
14%
Dipeptide
14%
Boronic Acid Derivative
14%
Hematologic Malignancy
14%
Myeloma
14%
Cell Extract
14%
Proteasome
14%
Medicine and Dentistry
Proteasome Inhibitor
100%
Bortezomib
100%
Multiple Myeloma
28%
Cell Extract
14%
Myeloma Cell
14%
Hematologic Malignancy
14%
Benzyloxycarbonylleucylleucylleucinal
14%
Boronic Acid Derivative
14%
Dipeptide
14%
Proteasome
14%
Immunology and Microbiology
Proteasome
100%
Multiple Myeloma
66%
Cell Extract
33%
Myeloma Cell
33%
Dipeptide
33%